Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtype...
Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Triple-negative breast cancer (TNBC) is a collection of biologically diverse cancers characterized by distinct transcriptional patterns, biology, and immune composition. TNBCs subtypes include two basal-like (BL1, BL2), a mesenchymal (M) and a luminal androgen receptor (LAR) subtype. Through a comprehensive analysis of mutation, copy number, transc...
Alternative Titles
Full title
Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_0cee2f33898a4f86bcaa6cb1a2d39df1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0cee2f33898a4f86bcaa6cb1a2d39df1
Other Identifiers
ISSN
2041-1723
E-ISSN
2041-1723
DOI
10.1038/s41467-021-26502-6
